Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension.
作者信息
Badlam Jessica B, Austin Eric D
机构信息
University of Colorado at Denver - Anschutz Medical Campus, Aurora, CO, USA.
Dept of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
出版信息
Eur Respir J. 2018 Jun 28;51(6). doi: 10.1183/13993003.01058-2018. Print 2018 Jun.
Abstract
摘要
相似文献
1
Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension.超越雌激素：对肺动脉高压激素谱进行更广泛评估
Eur Respir J. 2018 Jun 28;51(6). doi: 10.1183/13993003.01058-2018. Print 2018 Jun.
2
Response to letter "Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: Methodological issues".对信件《三种主要结缔组织病相关肺动脉高压的临床特征与生存情况：方法学问题》的回复
Int J Cardiol. 2017 Dec 15;249:418. doi: 10.1016/j.ijcard.2017.06.126.
3
Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: Methodological issues.与三种主要结缔组织病相关的肺动脉高压的临床特征与生存情况：方法学问题
Int J Cardiol. 2017 Dec 15;249:417. doi: 10.1016/j.ijcard.2017.06.063.
4
Decoding the Link Between Inflammation and Pulmonary Arterial Hypertension.解读炎症与肺动脉高压之间的联系
Circulation. 2022 Sep 27;146(13):1023-1025. doi: 10.1161/CIRCULATIONAHA.122.059949. Epub 2022 Sep 26.
5
Near infrared spectroscopy for the assessment of peripheral tissue oxygenation in pulmonary arterial hypertension.用于评估肺动脉高压患者外周组织氧合的近红外光谱技术
Eur Respir J. 2016 Oct;48(4):1224-1227. doi: 10.1183/13993003.01022-2016. Epub 2016 Sep 1.
6
Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research.抑制雌激素信号通路在肺动脉高压中的作用：性别、药物与研究
Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.00983-2017. Print 2017 Aug.
7
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights.联合波生坦和西地那非治疗单药治疗失败的肺动脉高压患者：真实世界的观察。
Eur Respir J. 2015 Aug;46(2):414-21. doi: 10.1183/09031936.00209914. Epub 2015 May 28.
8
ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad.血管紧张素转换酶2作为肺动脉高压的治疗手段：利大于弊。
Eur Respir J. 2018 Jun 21;51(6). doi: 10.1183/13993003.00848-2018. Print 2018 Jun.
9
10
Immunity Comes to Play in the "Sex Paradox" of Pulmonary Arterial Hypertension.免疫在肺动脉高压的“性别悖论”中发挥作用。
Circ Res. 2018 Jun 8;122(12):1635-1637. doi: 10.1161/CIRCRESAHA.118.313075.
引用本文的文献
1
Exploring the pathogenesis of pulmonary vascular disease.探索肺血管疾病的发病机制。
Front Med (Lausanne). 2024 Jul 10;11:1402639. doi: 10.3389/fmed.2024.1402639. eCollection 2024.
2
Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension.表观遗传机制作为新兴治疗靶点及微流控芯片在肺动脉高压中的应用
Biomedicines. 2022 Jan 13;10(1):170. doi: 10.3390/biomedicines10010170.
3
Newer insights into the pathobiological and pharmacological basis of the sex disparity in patients with pulmonary arterial hypertension.肺动脉高压患者性别差异的病理生物学和药理学基础的新认识。
Am J Physiol Lung Cell Mol Physiol. 2021 Jun 1;320(6):L1025-L1037. doi: 10.1152/ajplung.00559.2020. Epub 2021 Mar 10.
4
17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin.17β-雌二醇和雌激素受体 α 通过 BMPR2 和 apelin 保护肺动脉高压患者的右心功能。
J Clin Invest. 2021 Mar 15;131(6). doi: 10.1172/JCI129433.
5
Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension.雌二醇代谢：肺动脉高压的交汇点。
Int J Mol Sci. 2019 Dec 23;21(1):116. doi: 10.3390/ijms21010116.
本文引用的文献
1
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.DHEA-S 水平较低预示着特发性、结缔组织疾病相关性和先天性心脏病相关性肺动脉高压的绝经后女性发生疾病和不良结局。
Eur Respir J. 2018 Jun 28;51(6). doi: 10.1183/13993003.00467-2018. Print 2018 Jun.
2
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.依普利酮可减轻肺动脉高压中的病理性肺血管重构而非右心室重构。
BMC Pulm Med. 2018 Mar 2;18(1):41. doi: 10.1186/s12890-018-0604-x.
3
Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database.肺动脉高压退伍军人的性别差异：来自退伍军人事务部临床评估报告与追踪数据库的结果
PLoS One. 2017 Nov 9;12(11):e0187734. doi: 10.1371/journal.pone.0187734. eCollection 2017.
4
Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research.抑制雌激素信号通路在肺动脉高压中的作用：性别、药物与研究
Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.00983-2017. Print 2017 Aug.
5
Pregnancy in pulmonary arterial hypertension.肺动脉高压合并妊娠
Eur Respir Rev. 2016 Dec;25(142):431-437. doi: 10.1183/16000617.0079-2016.
6
Pulmonary Arterial Hypertension and the Sex Hormone Paradox.肺动脉高压与性激素悖论。
Curr Hypertens Rep. 2016 Nov;18(11):84. doi: 10.1007/s11906-016-0689-7.
7
Mechanistic Pathways of Sex Differences in Cardiovascular Disease.心血管疾病中性别差异的机制途径。
Physiol Rev. 2017 Jan;97(1):1-37. doi: 10.1152/physrev.00021.2015.
8
Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.阿那曲唑治疗肺动脉高压：一项随机、双盲、安慰剂对照试验
Am J Respir Crit Care Med. 2017 Feb 1;195(3):360-368. doi: 10.1164/rccm.201605-1024OC.
9
Estrogens in Men: Another Layer of Complexity of Estradiol Metabolism in Pulmonary Hypertension.男性体内的雌激素：肺动脉高压中雌二醇代谢复杂性的另一层面
Am J Respir Crit Care Med. 2016 May 15;193(10):1087-90. doi: 10.1164/rccm.201512-2541ED.
10
Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension.醛固酮上调雷帕霉素靶蛋白复合物1亚基Raptor可诱导异常的肺动脉平滑肌细胞存活模式，从而促进肺动脉高压。
FASEB J. 2016 Jul;30(7):2511-27. doi: 10.1096/fj.201500042. Epub 2016 Mar 22.
Zotero 插件